| Pulmonary long-term consequences of COVID-19 infections after hospital discharge JR Blanco, MJ Cobos-Ceballos, F Navarro, I Sanjoaquin, ... Clinical Microbiology and Infection 27 (6), 892-896, 2021 | 119 | 2021 |
| Simplification to dual therapy (atazanavir/ritonavir+ lamivudine) versus standard triple therapy [atazanavir/ritonavir+ two nucleos (t) ides] in virologically stable patients … JA Perez-Molina, R Rubio, A Rivero, J Pasquau, I Suarez-Lozano, ... Journal of Antimicrobial Chemotherapy 72 (1), 246-253, 2016 | 74 | 2016 |
| Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease J Olalla, F Pulido, R Rubio, A Costa M, R Monsalvo, E Palenque, ... The International Journal of Tuberculosis and Lung Disease 6 (1), 71-75, 2002 | 73 | 2002 |
| Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 61 | 2021 |
| Mycobacterium fortuitum complex endocarditis—case report and literature review J Olalla, M Pombo, JM Aguado, E Rodríguez, E Palenque, JR Costa, ... Clinical microbiology and infection 8 (2), 125-129, 2002 | 51 | 2002 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 48 | 2020 |
| The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance A Del Arco, B Tortajada, J De La Torre, J Olalla, JL Prada, F Fernández, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 247-251, 2015 | 46 | 2015 |
| Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience J Olalla, AM Correa, MD Martín-Escalante, ML Hortas, ... QJM: An International Journal of Medicine 113 (11), 794-798, 2020 | 37 | 2020 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 33 | 2021 |
| Ankle–branch index and HIV: the role of antiretrovirals J Olalla, D Salas, A Del Arco, J De la Torre, JL Prada, ... HIV medicine 10 (1), 1-5, 2009 | 33 | 2009 |
| Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain V Estrada, JI Bernardino, M Masiá, JA Iribarren, A Ortega, F Lozano, ... HIV clinical trials 16 (2), 57-65, 2015 | 29 | 2015 |
| Durability of the first antiretroviral treatment regimen and reasons for change in patients with HIV infection J De La Torre-Lima, A Aguilar, J Santos, F Jiménez-Oñate, M Marcos, ... HIV Clinical Trials 15 (1), 27-35, 2014 | 25 | 2014 |
| Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice M Alvarez, P Casas, A de Salazar, N Chueca, C Guerrero-Beltran, ... Journal of Antimicrobial Chemotherapy 74 (6), 1693-1700, 2019 | 24 | 2019 |
| Deprescribing of non-antiretroviral therapy in HIV-infected patients JR Blanco, R Morillo, V Abril, I Escobar, E Bernal, C Folguera, F Brañas, ... European Journal of Clinical Pharmacology 76, 305-318, 2020 | 23 | 2020 |
| Effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of HIV-infected patients over 50 years of age J Olalla, JMG de Lomas, N Chueca, X Pérez-Stachowski, A De Salazar, ... Medicine 98 (42), e17528, 2019 | 22 | 2019 |
| Ankle-brachial index in HIV infection J Olalla, D Salas, J de la Torre, A Del Arco, JL Prada, F Martos, ... AIDS Research and Therapy 6, 1-5, 2009 | 20 | 2009 |
| Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open … RL López, SC Fernández, LL Pérez, AR Palacios, MC Fernández-Roldán, ... BMJ open 10 (11), e039951, 2020 | 19 | 2020 |
| Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016 S Moreno, A Antela, F García, J Del Amo, V Boix, P Coll, C Fortuny, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 35 (6), 377-383, 2017 | 19 | 2017 |
| Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART R Palacios, IA Pérez-Hernández, MA Martínez, ML Mayorga, ... European Journal of Clinical Microbiology & Infectious Diseases 35, 815-819, 2016 | 19 | 2016 |
| Results of a counselling programme in antibiotic treatment in a secondary hospital A del Arco, B Tortajada, J de la Torre, J Olalla, JL Padra, N Montiel, ... Revista espanola de quimioterapia: publicacion oficial de la Sociedad …, 2011 | 19* | 2011 |
